文献速递头颈外科

探索头颈部放疗后淋巴水肿与纤维化的定量MRI生物标志物:一项前瞻性试验的事后分析

Exploring Quantitative MRI Biomarkers of Head and Neck Post-Radiation Lymphedema and Fibrosis: Post Hoc Analysis of a Prospective Trial.
PubMed 文献 · Head Neck · 2025-01-10

本研究为前瞻性试验的事后分析,探讨T1、T2加权MRI信号强度与头颈部淋巴水肿和纤维化(HN-LEF)物理触诊分类的关系,以及MRI结构体积与新型10分HN-LEF评分的关系。结果发现T2信号强度在A-B和C类高于D类和No-LEF类,T1信号强度A-B类最高;6对口底体积与邻近可触及部位的HN-LEF评分呈强负相关(p<0.05)。结论认为MRI信号强度和结构体积可能成为水肿软组织状态的影像生物标志物。

要点

  • T2信号强度在A-B和C类高于D类和No-LEF类,T1信号强度A-B类最高。
  • 6对MRI口底体积与邻近可触及部位HN-LEF评分呈强负相关(p<0.05)。
  • MRI信号强度和结构体积可能成为水肿软组织状态的影像生物标志物。

核心结论

  • MRI信号强度和结构体积可能成为头颈癌患者水肿软组织状态的影像生物标志物。

研究设计与样本

  • 前瞻性试验的事后分析,检查T1和T2加权MRI信号强度与HN-LEF物理触诊分类的关系,以及MRI结构体积与新型10分HN-LEF评分的关系。

主要发现

  • T2信号强度在A-B和C类高于D类和No-LEF类,T1信号强度A-B类最高。
  • 6对MRI口底体积与邻近可触及部位HN-LEF评分呈强负相关(p<0.05)。

关键数值与推荐

  • HN-LEF物理触诊分类:No-LEF、A-B=水肿、C=水肿+纤维化、D=纤维化。
  • 新型10分HN-LEF评分用于口腔内和颏下区域。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Quantifying head and neck lymphedema and fibrosis (HN-LEF) is crucial in the investigation and management of treatment sequelae in head and neck cancer (HNC). METHODS: The T1- and T2-weighted MRI signal intensity (SI) was examined in relation to HN-LEF categories per physical/tactile examination (No-LEF, A-B = edema, C = edema + fibrosis, D = fibrosis), and MRI structural volumes were examined in relation to a novel 10-point HN-LEF score in the intraoral and submental regions. RESULTS: We identified differences in ranks among HN-LEF categories in relation to the MRI SI (A-B and C are higher than D and No-LEF for T2 SI, and A-B is the highest for T1). Furthermore, six pairs of FOM volumes on MRI demonstrated a strong negative correlation (p < 0.05) with the HN-LEF score at adjacent palpable sites. CONCLUSION: Both MRI SI and structural volumes can potentially be imaging biomarkers of edematous soft tissue states in HNC patients.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Mao S, Wang J, McMillan H, et al. Exploring Quantitative MRI Biomarkers of Head and Neck Post-Radiation Lymphedema and Fibrosis: Post Hoc Analysis of a Prospective Trial. Head Neck. 2025. PMID: 39794912. doi:10.1002/hed.28062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。